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Abstract
Background: Hepatitis B infection is the major cause of acute and chronic liver disease, cirrhosis and hepatocellular 
carcinoma worldwide and has long been recognized as an occupational hazard among dentists. The aim of the 
present study was to examine factors associated to the self-reporting of hepatitis B vaccination and immunization 
status among dentists working in the city of Belo Horizonte, Brazil.
Methods: A cross-sectional survey was carried out with 1302 dentists in Belo Horizonte, Brazil. After signing a term of 
informed consent, the participants answered a structured questionnaire on their knowledge regarding their 
vaccination and immunization status against hepatitis B. Data on demographic, behavioural and occupational 
exposure aspects were also collected through questionnaires.
Results: The results revealed that 73.8% of the dentists reported having received three doses of the vaccine. 
Multivariate analysis revealed that gender (p = 0.006), use of individual protective equipment (p = 0.021), history of 
blood transfusion (p = 0.024) and history of illicit drug use (p = 0.013) were independently associated with vaccination 
against hepatitis B. Only 14.8% had performed a post-vaccination test. The use of individual protective equipment (p = 
0.038), dentists who asked patients about hepatitis during dental treatment (p < 0.001), a family history of hepatitis B (p 
= 0.003) and work experience (p < 0.05) were independently associated with the post-vaccination test.
Conclusions: Although there were a large number of vaccinated dentists in Belo Horizonte, the percentage was less 
than what was expected, as Brazil offers the National Program of Viral Hepatitis Vaccination, which provides free 
hepatitis B vaccinations to all healthcare workers. Despite being part of a high risk group for contamination, most of the 
dentists did not know their immunization status.
Background
Hepatitis B virus (HBV) is the major cause of acute and
chronic liver disease, cirrhosis and hepatocellular carci-
noma worldwide and has long been recognized as an
occupational hazard among dentists [1-6]. A third of the
world population (two billion people) has evidence of
hepatitis exposure and an estimated 400 million are
actively infected [3,7]. HBV is one of the major diseases of
mankind and is a serious global public health problem
[8,9]. HBV is transmitted primarily through parenteral
and sexual exposure to HBsAg-positive blood or other
body fluids from individuals who are chronic HBV carri-
ers or have acute hepatitis B [2]. These chronically
infected individuals are at high risk of death from cirrho-
sis of the liver and liver cancer, diseases that kill about
one million people each year [10,11].
As the dental profession involves the use of small, sharp
instruments contaminated with blood or other fluids,
there is ample opportunity for inadvertent skin wounds
to the operator and staff [1,2,12]. Such accidents include
the possibility of transmission of hepatitis B, hepatitis C
and human immunodeficiency virus (HIV) [13]. To
decrease the risk of HBV infection, it is recommended
that dental personnel receive immunization against HBV
and use individual protective equipment, such as gloves,
to prevent blood-borne infection during dental proce-
dures [1,11].
The hepatitis B vaccine has been available since 1982
and, since 1990, has been recommended for healthcare
workers whose activities frequently expose them to blood
[7,10,11,14]. However, 5 to 10% of normal subjects do not
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produce the anti-hepatitis B surface antibody (anti-HBs)
after receiving a standard course of HBV vaccine
[7,15,16]. Thus, post-vaccination testing one to three
m o n t h s  f o l l o w i n g  t h e  t h i r d  d o s e  o f  v a c c i n e  i s  r e c o m -
mended for healthcare workers who have contact with
blood [7]. Previous studies carried out in other countries
have revealed different proportions of self-reported vac-
cination, ranging from 40.3% to 97.0% [17-23]. The pro-
portion of dentists who have had their antibody titer
evaluated ranges from 36.5% to 47.9% [20,21]. In Brazil,
one study found that only 73.1% of dentists had been sub-
mitted to the three doses of the vaccine [24].
There is little information on factors associated to
adherence to the vaccination and the evaluation of immu-
nization status regarding hepatitis B among dentists. The
aim of the present study was to examine factors associ-
ated to the self-reporting of hepatitis B vaccination and
immunization status among dentists working in the city
of Belo Horizonte, Brazil.
Methods
This is a cross-sectional study nested in a larger study
assessing factors associated to the seroprevalence of hep-
atitis C among dentists in the city of Belo Horizonte, Bra-
zil. The dentists were first contacted, enrolled and invited
to take part in the study in November 2004, when all den-
tists registered at the Minas Gerais Dental Council were
required to elect the administrative board of the council.
Belo Horizonte is the capital of the state of Minas Gerais
and is an industrialized city with about 2.4 million inhab-
itants. The sample size was calculated to give a 95% confi-
dence interval, 0.75% precision level [25] and using a 3%
prevalence of hepatitis C [10]. The inclusion criteria were
dentists living and working in the city of Belo Horizonte
and registered at the Minas Gerais Dental Council. This
group consists of a finite population of 2766 dentists. The
minimal sample size to satisfy the requirements was esti-
mated as 1156 dentists. Taking into account the possibil-
ity of losses, a correction factor of 1.2 was adopted,
totalling an expected sample size of 1387 dentists. These
dentists scheduled a visit at the clinical analysis labora-
tory of the Medical School of the Federal University of
Minas Gerais. A total sample of 1302 dentists (response
rate = 93.9%) answered the questionnaire between
December 2004 and June 2006. The sampling strategy is
detailed in a previous article [26]. All participants signed
a term of informed consent and data were collected on
demographic, behavioural and occupational exposure
aspects.
Questionnaire
A self-administered questionnaire consisting of twenty
open-ended and close-ended items was used for the data
collection. The drafting of this questionnaire complied
with all steps proposed by previous studies [27,28]. Once
the purpose of the study and its conceptual basis were
defined, the drafting of the items was carried out by
means of a broad-based review of the literature [29-32].
Content validation was performed to determine the suit-
ability of the theoretical content and functionality of the
questionnaire. Item selection, adaptation and additional
inclusions were then performed based on the opinion of
an expert in research and marketing. An opinion was
subsequently formed by a commission made up of profes-
sionals from different dental institutions and specialties.
Unanimity in the approval of the questionnaire was
required for validation. Suggestions for changes were
heeded when brought up repeatedly by different commis-
sion members. Response options were organized verti-
cally. All survey items were constructed in the same
format in order to avoid placing emphasis on any specific
item [26].
In the present study, the following variables were taken
into account:
1- Personal and behavioural data
Gender; sexual behaviour (unprotected homo/hetero sex
with a casual partner); blood transfusion; previous his-
tory of hepatitis in participant or family member; and use
of illicit injection drugs. Since the latter variable is quite
sensitive, this point was addressed in combination with
exposure factors, such as the use of piercing and tattoos,
history of any kind of transplant, dialysis, colonoscopy
and chemotherapy.
2- Professional, behavioural and occupational exposure data
Work experience; workplace; field of work; use of individ-
ual protective equipment (IPE); vaccination for hepatitis
B; immunization against hepatitis B; history and number
of needle stick accidents with visible bleeding; dental
assistance for patients with hepatitis; and whether the
dentists' clinical dental chart contains a question on a his-
tory of hepatitis.
As individuals may go to school at any time in their
lives and the number of years of professional activity may
be more important than age in representing exposure to
risk factors, the age of the participants was not inquired,
but rather the duration of activity (work experience). To
analyze the influence of work experience, the sample was
categorized into four groups: less than 10 years; 10 to 20
years; 21 to 30 years; and 30 years or more. The work-
place was considered public, private or both.
Data were analyzed using the Statistical Package for the
Social Sciences (SPSS for Windows, version 17.0, SPSS
Inc, Chicago, IL, USA). Bivariate analysis was the initial
analytic strategy (Fisher's exact test and Pearson's chi-
square test). Multivariate Poisson regression with robust
variance was then performed. Vaccination for hepatitis B
and immunization against hepatitis B were the dependent
variables. The level of significance was set at α = 0.05.Resende et al. Virology Journal 2010, 7:154
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Results
Among the total number of dentists surveyed, 87.1% (n =
1134) answered the question on hepatitis B vaccination
and 74.8% (n = 974) answered the question on immuniza-
tion for hepatitis B. Among the study sample (n = 1302),
73.9% reported having received the three doses of the
vaccine. There was an association between vaccination
against hepatitis B and gender (p = 0.003), use of IPE (p =
0.001), blood transfusion (p = 0.006) and combined fac-
tors (p = 0.026) in the univariate analysis (Table 1). The
multivariate analysis revealed that women had a 1.06-fold
(95%CI: 1.02-1.10) greater frequency of vaccination
against hepatitis B than men. Dentists who reported the
use of IPE had a 1.05-fold (95%CI: 1.01-1.09) greater
prevalence of vaccination. Dentists who reported having
received no blood transfusions had a 1.10-fold (95%CI:
1.01-1.21) greater prevalence of vaccination. Dentists
reported having no combined risk factors had a 1.08-fold
(95%CI: 1.02-1.15) greater prevalence of vaccination
(Table 2).
When asked whether they knew their immunization
status or had performed a post-vaccination test, 14.8% of
the total sample reported having taken the test. Immuni-
zation status was associated with work experience (p =
0.003), the use of IPE (p = 0.003), dental care for patients
with hepatitis (p = 0.011), the custom of asking patients
about hepatitis during dental treatment (p = 0.001) and a
family history of hepatitis (p = 0.004) (Table 3). The mul-
tivariate analysis revealed that dentists who reporting the
use of IPE had a 1.03-fold (95%CI: 1.00-1.07) greater
prevalence of vaccination. Dentists who asked patients
about hepatitis had a 1.07-fold (95%CI: 1.04-1.11) greater
prevalence of immunization. Dentists who reported a
family history of hepatitis had a 1.06-fold (95%CI: 1.02-
1.12) greater prevalence of immunization. Dentists with
less than 10 years of experience had a 1.07-fold (95%CI:
1.02-1.12) greater prevalence of immunization when
compared to dentists with more than 30 years of experi-
ence. Dentists with 10 to 20 years of experience had a
1.07-fold (95%CI: 1.02-1.13) greater prevalence of immu-
nization when compared to dentists with more than 30
years of experience. There was no difference in the preva-
lence of immunization between those with 20 to 30 years
of experience and those with more than 30 years of expe-
rience (Table 4).
Discussion
Prevention is ultimately the most efficient and humane
means toward improved health [33]. Immunization pro-
grams are highly effective, clearly protect populations and
individuals at risk and are leading to the elimination of
hepatitis B [34]. Viral hepatitis is preventable with effec-
tive vaccines, which have been available since 1982 and
have proven safe to both adults and children [7,10]. How-
ever, despite being safe, efficacious and cost-effective,
hepatitis B vaccination remains consistently under-
employed [34].
Reports from different countries reveal that some den-
tists do not engage in safe practices, such as the use of
gloves, facemasks or protective eyeglasses. Moreover,
hepatitis B virus vaccination coverage is not complete
among dentists, as reported for countries such as Nigeria,
Jordan, Iran and the United Kingdom [17-23].
The results of the present study reveal that an average
of 73.8% of the dentists had taken the three doses of the
hepatitis B vaccine. The Brazilian Ministry of Health
offers the National Viral Hepatitis Program, which has
provided free vaccinations for newborn children, adoles-
cents, those who work in the sex industry and healthcare
workers since 1998. Thus, a higher number of vaccinated
dentists was expected. However, this is a good coverage
compared to countries that do not have government vac-
cination programs, such as Kenya, where only 12.8% of
healthcare workers have been vaccinated for hepatitis B
[23]. It is important to point out the differences between
the two studies: The present study was carried out in a
large city, whereas the Kenyan study was carried out in
Thika, which is a typical small Kenyan district [23]. The
number of vaccinated dentists in the present study was
also higher than that reported for correctional healthcare
workers in three American states, in which only 64% of
the 411 professionals interviewed reported having
received all three doses of the vaccine [35]. On the other
hand, vaccination coverage among English dentists is
quite higher than that reported in the present study [22].
Female dentists, dentists who use IPE and those who
reported the use of illicit drugs had a greater prevalence
of vaccination for hepatitis B. A study carried out in the
city of Recife (Brazil) found that women adhere to infec-
tion control measures more than male dentists [36]. It is
troubling that dentists who use illicit drugs and those
with a history of blood transfusion have a lower propor-
tion of adherence to the vaccination than those who do
not report these factors, considering the increased risk
[2]. On the other hand, it appears that the dentists who
adhere more to infection control measures, such as the
use of EPI, also have a higher prevalence of vaccination.
This finding is similar to that reported in a study carried
out in Iran [20].
Regarding vaccination status, there were no differences
in relation to work experience. This may be explained by
the fact that all the three dental schools in the city of Belo
Horizonte offer an immunization program for their stu-
dents before initiating dental practice, which explains
why most of the dentists are vaccinated, especially those
recently graduated. Those with a longer-standing profes-
sion may have been vaccinated during a campaign by the
Dental Council of Minas Gerais in 1996, when all dentistsResende et al. Virology Journal 2010, 7:154
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Table 1: Factors associated with self-reporting of hepatitis B vaccination among Brazilian dentists, Belo Horizonte, 2005
Hepatitis B vaccination p-value
Yes No Total
Gender
Male 288 71 359 0.003*
Female 674 101 775
Total 962 172 1134
Work experience††
Less than 10 years 264 42 306 0.431*
10 - 20 years 256 41 297
21 - 30 years 319 51 370
More than 30 years 115 27 142
Total 954 161 1115
Workplace††
Public 202 34 236 0.945*
Private 408 72 480
Both 274 50 324
Total 884 156 1040
Field ††
General dentistry 409 52 461 0.067**
Oral Surgery/Periodontology 109 20 129
Operative Dentistry/Endodontics 131 27 158
Paediatric Dentistry/Orthodontics 112 26 138
Oral Public Health 38 4 42
Oral Pathology/Oral Radiology 18 6 24
Total 817 135 952
Use of IPE
Yes 631 91 722 0.001*
No 331 81 412
Total 962 172 1134
Needle stick accidents††
Yes 829 139 968 0.065*
No 128 32 160
Total 957 171 1294
Dental care for hepatitis patients ††
Yes 264 44 308 0.928*
No 489 83 572
Total 753 127 880
Question on patient history of hepatitis ††
Yes 799 132 931 0.087*
No 153 36 189
Total 952 168 1120Resende et al. Virology Journal 2010, 7:154
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Unprotected homo/hetero sex††
Yes 202 37 239 0.862*
No 752 133 885
Total 954 170 1124
Blood transfusion††
Y e s 4 21 65 80 . 0 0 6 *
No 881 147 1028
Total 923 163 1086
Previous history of hepatitis††
Yes 100 15 115 0.529*
No 816 147 963
Total 916 162 1078
Family history of hepatitis ††
Yes 227 34 261 0.387*
No 521 94 615
Total 748 128 876
Combined question†, ††
Yes 106 29 135 0.026*
No 829 137 966
Total 935 166 1101
* Pearson's chi-square test ** Fisher's exact test
† This question included use of illicit injection drugs, piercings and tattoos, blood transfusion, transplant, history of dialysis, colonoscopy or 
chemotherapy.
††: For these variables, the sum of the data does not result in 100%, as these questions were not answered by the entire sample.
Table 1: Factors associated with self-reporting of hepatitis B vaccination among Brazilian dentists, Belo Horizonte, 2005 (Continued)
in the state were offered free vaccinations. However, vac-
cination goes beyond taking vaccines; it implies a moni-
toring process, which is seldom considered including all
vaccine series and over the lifetimes of individuals [33].
There was a very low prevalence of hepatitis B immuni-
za t i o n .  S t u d i e s  ca rri ed  o u t  i n  I r a n  r e po rt  t h a t  d e n t is ts
take the test for the evaluation of immunization status
with a frequency least 2.5-fold greater than Brazilian den-
tists [20,21]. This finding underscores the need for collec-
tive actions for raising the awareness of Brazilian dentists
with regard to the evaluation of immunization status for
this disease.
Dentists who adequately employ IPE, those who obtain
a patient history regarding hepatitis B, those with a family
history of hepatitis B and those more recently graduated
had a greater frequency of self-reported immunization
for hepatitis B. As mentioned above, dentists with a more
favourable behaviour with regard to infection control
measures are more apt to adhere to an immunization
evaluation. Living with the disease in the family setting
may have sensitized these dentists to adhering to every
prevention protocol in the professional setting. Likewise,
dentist who more recently graduated may have been sub-
Table 2: Adjusted factors associated with self-reporting of 
hepatitis B vaccination among Brazilian dentists, Belo 
Horizonte, 2005
Prevalence Ratio
(95%CI)
p-value
Gender
Female 1.06 (1.02-1.10) 0.006
Male 1
Use of IPE
Yes 1.05 (1.01-1.09) 0.021
No 1
Blood transfusion
No 1.10 (1.01-1.21) 0.024
Yes 1
Combined question
No 1.08 (1.02-1.15) 0.013
Yes 1Resende et al. Virology Journal 2010, 7:154
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Table 3: Factors associated with self-reporting of hepatitis B post-vaccination test among Brazilian dentists, Belo 
Horizonte, 2005
Knowledge on immunization status p-value
Yes No Total
Gender
Male 55 256 311 0.253*
Female 138 525 663
Total 193 781 974
Work experience††
Less than 10 years 65 222 287 0.003*
10 - 20 years 62 182 244
21 - 30 years 55 264 319
More than 30 years 11 99 110
Total 193 767 960
Workplace††
Public 45 155 200 0.511*
Private 76 332 408
Both 58 221 279
Total 179 708 887
Field††
General dentistry 72 328 400 0.085**
Oral Surgery/Periodontology 35 87 122
Operative Dentistry/Endodontics 21 104 125
Paediatric Dentistry/Orthodontics 27 98 125
Oral Public Health 4 26 30
Oral Pathology/Oral Radiology 5 11 16
Total 164 654 818
Use of IPE
Yes 142 484 626 0.003
No 51 297 348
Total 193 781 974
Needle stick accidents††
Yes 171 663 834 0.227
No 22 115 137
Total 193 778 971
Dental care for hepatitis patients ††
Yes 69 199 268 0.011
No 89 406 495
Total 158 605 763Resende et al. Virology Journal 2010, 7:154
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Question on patient history of hepatitis ††
Yes 176 626 802 0.001
No 17 144 161
Total 193 770 962
Unprotected homo/hetero sex††
Yes 37 157 194 0.790
No 154 619 773
Total 191 776 967
Blood transfusion††
Yes 7 40 47 0.393
No 179 717 896
Total 186 757 943
Previous history of hepatitis††
Yes 23 77 100 0.459
No 164 662 826
Total 187 739 926
Family history of hepatitis ††
Yes 61 164 225 0.004
No 96 444 540
Total 157 608 765
Combined question†, ††
Yes 26 107 188 0.935
No 162 654 761
Total 188 816 949
* Pearson's chi-square test ** Fisher's exact test
† This question included use of illicit injection drugs, piercings and tattoos, blood transfusion, transplant, history of dialysis, colonoscopy or 
chemotherapy.
††: For these variables the sum of the data does not result in 100% as these questions were not answered by the entire sample.
Table 3: Factors associated with self-reporting of hepatitis B post-vaccination test among Brazilian dentists, Belo 
Horizonte, 2005 (Continued)
mitted to a different training/education process in rela-
tion to infection control measures. Further education
may be appropriate in order to impress upon dental stu-
dents and dentists alike the importance of knowledge on
their own vaccination and immunization status.
The present study has some limitations that must be
recognized. Cross-sectional studies are carried out either
at a single point in time or over a short period. Thus,
associations identified in cross-sectional studies should
not be considered a causal relationship. However, there is
a lack of studies that concomitantly assess the knowledge
of dentists regarding their own hepatitis vaccination and
immunization status, as we performed in the present
study.
Given the huge burden of hepatitis B infection world-
wide and the number of advances made in the past sev-
e r a l  d e c a d e s ,  i t  i s  s u r p r i s i n g  t h a t  m o r e  p r o g r e s s  i n
limiting the infection has not been made. Hepatitis B
continues to spread in endemic areas where universal
vaccination has not yet been achieved. The availability of
the vaccine and its use in preventing neonatal transmis-
sion as well as the increasing use of suppressive therapies
should yield greater gains in the eradication of hepatitis B
in upcoming generations [3,4]. Moreover, dentists shouldResende et al. Virology Journal 2010, 7:154
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be better instructed with regard to the importance of
compliance to the vaccination and taking the post-vacci-
nation test in order to assist in the elimination of hepatitis
B.
Conclusions
The prevalence of hepatitis B vaccination among Brazil-
ian dentists was associated to gender, blood transfusion
and risk behaviours. A low percentage of dentists
reported having taken the post-vaccination test and few
were aware of their immunization status. We strongly
recommend that dentists, as a potential risk group,
should know their immunization status so that those who
require revaccination can obtain it.
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